Indivior Pharmaceuticals, Inc.

INDV

Indivior Pharmaceuticals, Inc.

INDV

Insider Sentiment (TTM):

Last Purchase:2026-03-13Last Sale:2026-06-11Shares Purchased (TTM):5,850Shares Sold (TTM):54,586

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:116,487,133Shares Outstanding:124,000,000Institutional Ownership Pct.:93.94%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	222	175	195	445	510	372	319
Short Term Investments	-	-	0	0	0	1	1
Accounts Receivable Net Current	271	273	253	259	240	243	254
Inventory Net	150	152	153	155	149	163	167
Prepaid Expense Current	14	15	34	30	28	56	31
Prepaid Expense And Other Assets Current	-	-	-	-	-	-	53
Income Taxes Receivable	16	12	2	13	3	29	33
Deposits Assets Current	-	-	-	-	-	-	0
Other Assets Current	54	40	16	19	20	20	21
Assets Current	725	667	652	922	951	883	827
Long Term Investments	27	27	28	28	27	27	27
Property Plant And Equipment Net	162	157	144	124	117	104	100
Operating Lease Right Of Use Asset	21	22	26	30	35	37	39
Intangible Assets Net Including Goodwill	2	2	2	2	7	7	6
Deferred Income Tax Assets Net	271	296	323	285	270	279	277
Other Assets Noncurrent	24	26	27	27	44	39	39
Assets	1,233	1,197	1,201	1,416	1,452	1,375	1,316
Liabilities And Stockhold…
Liabilities Current
Contract With Customer Refund Liability Current	610	551	582	613	709	675	562
Accounts Payable And Accrued Liabilities Current	206	178	250	215	196	183	216
Litigation Reserve Current	14	14	42	106	105	105	99
Long Term Debt Current	0	0	29	18	18	18	18
Operating Lease Liability Current	9	9	10	10	11	11	10
Accrued Income Taxes Current	30	26	2	4	17	12	7
Other Liabilities Current	-	-	0	0	0	3	11
Liabilities Current	868	779	914	965	1,056	1,005	924
Long Term Debt Noncurrent	487	486	290	304	308	311	315
Litigation Reserve Noncurrent	42	41	52	300	299	297	365
Operating Lease Liability Noncurrent	13	14	22	24	29	30	32
Other Liabilities Noncurrent	31	21	21	30	18	17	18
Liabilities	1,441	1,341	1,300	1,623	1,709	1,660	1,652
Stockholders Equity
Common Stock Value	0	0	62	62	62	62	62
Additional Paid In Capital	155	165	112	109	101	93	90
Accumulated Other Comprehensive Income Loss Net Of…	-28	-29	-30	-32	-33	-35	-36
Retained Earnings Accumulated Deficit	-334	-280	-243	-346	-388	-406	-443
Stockholders Equity	-208	-144	-98	-207	-257	-285	-337
Liabilities And Stockholders Equity	1,233	1,197	1,201	1,416	1,452	1,375	1,316
Allowance For Doubtful Accounts Receivable Current	3	3	4	2	2	2	3
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.5	0.5	0.5	0.5	0.5
Common Stock Shares Issued	118	122	125	125	125	125	125

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.04%	4.13%	10.22%	-	-	-	-	-	-	-	-	-
2025	-2.51%	21.30%	38.61%	20.40%	11.44%	21.19%	12.43%	20.87%	11.71%	-13.08%	-3.00%	9.05%
2024	-	-	-	-	-	-	-	-	-	0.10%	21.05%	17.91%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Liquidity Ratios
Current Ratio	0.84	0.86	0.71	0.96	0.90	0.88	0.90
Quick Ratio	0.65	0.64	0.51	0.76	0.73	0.66	0.68
Working Capital	-143.00M	-112.00M	-262.00M	-43.00M	-105.00M	-122.00M	-97.00M
Leverage & Debt
Debt to Equity	-6.93	-9.31	-13.27	-7.84	-6.65	-5.82	-4.90
Interest Coverage TTM	15.59	8.33	5.82	4.64	-	-	-
Debt Ratio	1.17	1.12	1.08	1.15	1.18	1.21	1.26
Efficiency & Turnover
Asset Turnover TTM	0.99	1.00	0.98	0.62	-	-	-
Days Sales Outstanding TTM	70.07	73.00	74.68	107.18	-	-	-
Receivables Turnover TTM	5.21	5.00	4.89	3.41	-	-	-
Per Share Metrics
Diluted EPS TTM	2.87	1.95	1.64	0.83	-	-	-
Free Cash Flow Per Share TTM	-0.32	-1.55	-0.74	0.66	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	-	-	-
Margin Metrics
Gross Profit Margin TTM	82.19%	81.40%	80.23%	-	-	-	-
Operating Profit Margin TTM	31.63%	25.81%	21.15%	20.52%	-	-	-
Net Profit Margin TTM	26.75%	19.53%	16.95%	12.13%	-	-	-
Valuation Metrics
P/E TTM	13.72	15.00	21.36	28.17	-	-	-
P/B TTM	-23.47	-26.25	-45.77	-14.56	-7.17	-4.15	-4.87
P/S TTM	3.67	2.93	3.62	3.42	-	-	-
Market Cap	4.88B	3.78B	4.49B	3.01B	1.84B	1.18B	1.64B
Enterprise Value	5.15B	4.09B	4.61B	2.89B	1.66B	1.14B	1.65B
Calculated Values
Free Cash Flow TTM	-38.00M	-192.00M	-93.00M	82.00M	-	-	-
Net Debt	265.00M	311.00M	124.00M	-123.00M	-184.00M	-43.00M	14.00M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Sale

Owner: Heidbreder, Christian

Title: Chief Scientific Officer

Shares: 18,586

Price/Share: $38.06

Value: $707,383.16

Shares Owned: 227,923

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Preblick, Ryan

Title: Chief Financial Officer

Shares: 36,000

Price/Share: $37.70

Value: $1,357,200.00

Shares Owned: 284,751

Relationship: Officer

Ownership: Direct

2026-03-13Purchase

Owner: Ryan, Barbara

Title: -

Shares: 8

Price/Share: $31.09

Value: $248.72

Shares Owned: 5,724

Relationship: Director

Ownership: Direct

2026-03-09Purchase

Owner: Ryan, Barbara

Title: -

Shares: 31

Price/Share: $32.56

Value: $1,009.36

Shares Owned: 5,716

Relationship: Director

Ownership: Direct

2026-03-06Purchase

Owner: Kingsley, Stuart A

Title: -

Shares: 940

Price/Share: $31.87

Value: $29,957.80

Shares Owned: 5,582

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Heidbreder, Christian	Officer	Chief Scientific Officer	Direct	Sale	18,586	38.06	$707,383.16	227,923	4
2026-06-08	Preblick, Ryan	Officer	Chief Financial Officer	Direct	Sale	36,000	37.70	$1,357,200.00	284,751	4
2026-03-13	Ryan, Barbara	Director	-	Direct	Purchase	8	31.09	$248.72	5,724	4
2026-03-09	Ryan, Barbara	Director	-	Direct	Purchase	31	32.56	$1,009.36	5,716	4
2026-03-06	Kingsley, Stuart A	Director	-	Direct	Purchase	940	31.87	$29,957.80	5,582	4
2026-01-05	Ryan, Barbara	Director	-	Direct	Purchase	775	35.39	$27,427.25	1,963	4
2026-01-05	Humphreys, Keith	Director	-	Direct	Purchase	775	35.39	$27,427.25	5,802	4
2026-01-05	Stejbach, Mark	Director	-	Direct	Purchase	775	35.39	$27,427.25	16,847	4
2026-01-05	Wheadon, David E.	Director	-	Direct	Purchase	1,771	35.39	$62,675.69	14,395	4
2026-01-05	Ninivaggi, Daniel A	Director	-	Direct	Purchase	775	35.39	$27,427.25	16,923	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

93.94%

Inst. Shares: 116,487,133

Shares Outstanding: 124,000,000

2025-12-31

86.72%

Inst. Shares: 108,402,675

Shares Outstanding: 125,000,000

2025-09-30

84.13%

Inst. Shares: 105,159,913

Shares Outstanding: 125,000,000

2025-06-30

81.07%

Inst. Shares: 101,343,721

Shares Outstanding: 125,000,000

2025-03-31

70.29%

Inst. Shares: 87,165,570

Shares Outstanding: 124,000,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	116,487,133	124,000,000	93.94%
2025-12-31	108,402,675	125,000,000	86.72%
2025-09-30	105,159,913	125,000,000	84.13%
2025-06-30	101,343,721	125,000,000	81.07%
2025-03-31	87,165,570	124,000,000	70.29%
2024-12-31	75,164,897	132,000,000	56.94%
2024-09-30	66,577,703	132,000,000	50.44%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Indivior Pharmaceuticals, Inc. (INDV) — SEC Financial Statements & Analysis

Indivior Pharmaceuticals, Inc. (INDV) is a pharmaceutical preparations company, incorporated in DE. Indivior Pharmaceuticals, Inc. trades on Nasdaq as: INDV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Indivior Pharmaceuticals, Inc. reported a Gross Profit Margin of 82.19% (TTM), a Debt-to-Equity ratio of -6.93x, a Price-to-Sales (P/S) ratio of 3.67x (TTM), a Price-to-Book (P/B) ratio of -23.47x (TTM), at a market cap of $4.88B. Figures below are sourced from SEC EDGAR, as-filed.

Gross Profit Margin TTM: 82.19%
Debt To Equity: -6.93x
P/S TTM: 3.67x
P/B TTM: -23.47x
Market Cap: $4.88B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Indivior Pharmaceuticals, Inc. in?

Indivior Pharmaceuticals, Inc. (INDV) operates in the Pharmaceutical Preparations industry.

What is INDV's market cap?

Indivior Pharmaceuticals, Inc. (INDV) has a market capitalization of $4.88B as of 2026-06-30.

What is INDV's P/E ratio?

Indivior Pharmaceuticals, Inc. (INDV)'s trailing twelve month P/E ratio is 13.72x as of 2026-06-30.

What exchange does INDV trade on?

Indivior Pharmaceuticals, Inc. (INDV) trades on the Nasdaq.

Where is Indivior Pharmaceuticals, Inc. incorporated?

Indivior Pharmaceuticals, Inc. is incorporated in DE.